A lawsuit filed against a Florida assisted living facility indicates it gave an elderly resident multiple doses of the antipsychotic Invega, despite express warnings not to give the drug to dementia patients, resulting in numerous falls, injury and permanent loss of mobility.…
Federal inspectors have launched three investigations into potential nursing home neglect and abuse this month, with two focused on the response to COVID-19, and another into the use of psychotropic drugs as chemical restraints.…
A new study finds that FDA warnings reduced the use of antipsychotics as chemical restraints on elderly nursing home residents, but in many cases, the facilities may have switched to other drugs which caused different health problems.…
A new study finds that dementia patients treated at home may be more prone to injury and to suffer from unmet medical needs.…
A new study warns that giving dementia patients trazodone could be as risky as giving them atypical antipsychotics.…
Federal investigators report that a third of foster care children in the U.S. prescribed psychotropic drugs are given no treatment plan or medical monitoring while taking the powerful medications.…
Doctors, bioethicists and consumer watchdogs are calling for an investigation into clinical trials involving the non-consensual injection of ketamine and other sedatives into agitated patients.…
A federal judge cleared the way for a class action lawsuit against Missouri officials, who plaintiffs say allowed unmonitored and uncontrolled prescribing of psychotropic drugs to foster children.…
An AARP study warns that the use of antipsychotics as chemical restraints on elderly patients with dementia is increasing among those who do not live in nursing homes.…
A new report by Human Rights Watch details rampant overuse of antipsychotics in U.S. nursing homes, which are used as a form of chemical restraint on patients with dementia.…
